Header Ads

Brazil hits its stride

Here's the latest news from the global pandemic.

Brazil gets its act together

After months of delays and setbacks, Brazil has finally hit its stride in Covid-19 vaccinations. 

Relying on a decentralized public health-care system that's known for excelling in mass immunizations for everything from flu to measles, the country regularly administered more than 2 million doses a day in August, double the target the government set — and struggled to meet — earlier this year. Delays in shipments that often caused vaccinations to be halted for days or weeks are now rare. 

The so-called vaccine sommeliers, Brazilians who delayed the pace of the campaign by choosing which shot they wanted to take, have also seemingly changed tack: Some states like Sao Paulo, the country's most populous, report that more than 97% of adults have received a first dose. 

The steadier supply and more widespread acceptance have pushed up vaccination rates in Latin America's largest economy. About 64% of its population has now received at least one dose, making Brazil the latest major country to pass the U.S., whose rate is about 62%.

Residents wait in line to receive a dose of the Sinovac vaccine at the Allianz Parque Stadium in Sao Paulo in June. Brazilians no longer appear to be holding out for the Pfizer vaccine, which had delayed the nation's inoculation campaign.

Photographer: Rodrigo Capote/Bloomberg

But Brazil still lags when it comes to full immunization: Less than 30% of the country has received the two shots needed to keep the virus in check. That's because Brazil spaced out the interval between first and second doses to 12 weeks for AstraZeneca and Pfizer, two of the main vaccines being used, mostly to cope with the low supply. 

Officials have announced they're shortening the gap to eight weeks, which should help speed up the pace of the campaign. They'll also begin giving third doses to some groups starting in mid-September, joining countries from Chile to Israel in deploying booster shots to halt the spread of the delta variant.

The strain, which is estimated to be almost twice as infectious as the original virus from early 2020, has caused fresh flareups across the world. Yet, it's had a muted impact in Brazil so far. It's unclear how much delta has spread — there's far too little testing to know the actual toll — but by most measures the state of the pandemic in Brazil has improved. The number of deaths from the respiratory virus fell to 4,801 last week, a 10th straight drop, to the lowest in about eight months. 

The widespread decline, also seen in hospitalization and infection numbers, has allowed life to return to normal in most cities. The notable exception is Rio de Janeiro, which scuttled plans for a multiday reopening party in early September amid a rise in cases. —Julia Leite

Track the virus

Most Employers Say Vaccine Mandates Are Possible by End of Year

A majority of U.S. employers — 52% — are planning or considering requirements for a Covid-19 shot by the end of the year, according to a survey by consultant Willis Towers Watson. Get the full story here.

A vaccination event in Birmingham, Alabama.

Photographer: Andi Rice/Bloomberg

 

What you should read

Vaccines May Become a Viable Business
Where does that leave the rest of the world?
Argentina's Women Left Behind in Recovery
Unemployment gender gap has quadrupled since before Covid-19.
Melbourne Lays Out 70% Vaccine Target 
City has already seen more than 200 days of restrictions.
Deutsche Bank Requires Vaccination in New York
Rule applies to vendors, staff and clients at U.S. headquarters. 
Vietnam Supply Chain Highlights Global Threat
Southeast Asia factory woes worsen amid delta, shipping costs.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments